Markets.com Logo
markets.com

ETON

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    16.3293$
  • Previous Close
    17.0939$
  • 52 Week Change
    17.04$
  • Day Range
    -0.76$
  • 52 Week High/Low
    4.4401$ - 21.48$
  • Dividend Per Share
    --
  • Market cap
    458 M$
  • EPS
    0.03
  • Beta
    1.135
  • Volume
    --

About

ETON Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative products for underserved patient populations. The company's primary focus is on pediatric and rare disease markets. ETON.US is the stock ticker symbol used to identify and trade shares of Eton Pharmaceuticals, Inc. on the Nasdaq Stock Market. Investing in ETON.US involves risks, and potential investors should consult with a financial advisor before making any decisions.
markets.com
Coinbase Stock Forecast 2026–2030: Can COIN Recover as Bitcoin Nears $80,000?

Coinbase Stock Forecast 2026–2030: Can COIN Recover as Bitcoin Nears $80,000?

Julian Parker|--
Samsung Stock Forecast: Can AI Memory Demand Offset the Latest Sell-Off?

Samsung Stock Forecast: Can AI Memory Demand Offset the Latest Sell-Off?

Julian Parker|--
Robinhood Stock Forecast 2026–2030: Can Bitcoin’s Rally Drive HOOD Higher?

Robinhood Stock Forecast 2026–2030: Can Bitcoin’s Rally Drive HOOD Higher?

Julian Parker|--
Copper Price Forecast 2026, 2027 and 2030: Can Prices Hold Above $14,000?

Copper Price Forecast 2026, 2027 and 2030: Can Prices Hold Above $14,000?

Daniel Carter|--
Marvell Stock Forecast 2026 and 2030: Can MRVL Reach $300?

Marvell Stock Forecast 2026 and 2030: Can MRVL Reach $300?

Daniel Carter|--
Lumentum Holdings (LITE) Stock Forecast 2026–2030: Can AI Optics Sustain the Rally?

Lumentum Holdings (LITE) Stock Forecast 2026–2030: Can AI Optics Sustain the Rally?

Julian Parker|--
IBM Stock Forecast 2026–2030: Is IBM a Buy After Its 25% Q2 Drop?

IBM Stock Forecast 2026–2030: Is IBM a Buy After Its 25% Q2 Drop?

Julian Parker|--

Factors

ETON.US Stock Price Factors: Company Performance: Eton Pharmaceuticals' revenue, profitability, and product pipeline progress greatly influence investor confidence and stock price.

Regulatory Approvals: FDA decisions regarding Eton's drug candidates are critical. Approvals often lead to price increases, while rejections can cause declines.

Market Sentiment: Overall investor optimism or pessimism towards the pharmaceutical industry and small-cap stocks can impact ETON.US, regardless of company specifics.

Competition: The competitive landscape for Eton's drugs affects market share and pricing power, impacting revenue projections and stock valuation.

Financial Health: Eton's cash reserves, debt levels, and ability to fund research and development influence investor perception of its long-term viability.

Economic Conditions: Broader economic factors, such as interest rates and inflation, can affect investor appetite for riskier assets like ETON.US.

News and Events: Company-specific announcements, industry news, and unforeseen events can trigger immediate price reactions in ETON.US shares.

People Also Watch

Latest news

BTC Breaks $80K as ETF Inflows and Short Squeeze Fuel Rally

BTC Breaks $80K as ETF Inflows and Short Squeeze Fuel Rally

Julian Parker|--
Gold Price Today, August 25: XAU/USD Nears $4,700 as Safe-Haven Rally Accelerates

Gold Price Today, August 25: XAU/USD Nears $4,700 as Safe-Haven Rally Accelerates

Julian Parker|--
GBP/USD Today: Pound Holds Near Six-Month High as 1.3660 Breakout Looms

GBP/USD Today: Pound Holds Near Six-Month High as 1.3660 Breakout Looms

Julian Parker|--

Latest Education Articles

XAU/USD Trading Hours in Dubai: When Does the Gold Market Open?

XAU/USD Trading Hours in Dubai: When Does the Gold Market Open?

Daniel Carter|--
How to Trade Gold CFDs: A Beginner’s Guide to XAU/USD Trading

How to Trade Gold CFDs: A Beginner’s Guide to XAU/USD Trading

Daniel Carter|--
How to Read a Forex Chart: A Beginner’s Guide to Candlesticks and Trends

How to Read a Forex Chart: A Beginner’s Guide to Candlesticks and Trends

Daniel Carter|--
Recommended Topics
markets.com